Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KCT0010996Phase 2Completed
A Phase 2 trial of opiranserin in postoperative pain, sponsored by Vivozon. Started Sep 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on KCT0010996.